“The endocannabinoids and their attending cannabinoid (CB)(1) receptors have been implicated in the control of cognition, but their possible roles in dementias are still unclear.
The results suggest that an Aβ(42)-dependent impairment in brain anandamide mobilization contributes to cognitive dysfunction in AD.”
I do consider all the ideas you have offered on your post. They’re really convincing and will certainly work. Still, the posts are very quick for starters. May you please prolong them a bit from subsequent time? Thanks for the post.